Literature DB >> 19220839

CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells.

S H Blaas1, M Stieber-Gunckel, W Falk, F Obermeier, G Rogler.   

Abstract

Bacterial DNA motifs (such as CpG-oligodeoxynucleotides: CpG-ODN) induce innate immune responses via binding to Toll-like-receptor-9 (TLR-9). In murine intestinal mucosa treatment with CpG-ODN worsens chronic intestinal inflammation, whereas it prevents or ameliorates colitis when given in a prophylactic setting. In tonsils B cells have been reported to express TLR-9, especially after activation. Whether B cells in the human intestinal mucosa also express TLR-9 and whether their function can be influenced by CpG-ODN is, so far, unknown. Mucosal B cells were isolated according to a new protocol from surgical specimens of patients with inflammatory bowel disease and from controls by collagenase digestion followed by magnetic cell sorting using anti-CD19 antibody armed magnetic beads. TLR-9 mRNA and protein expression were quantified by real-time polymerase chain reaction (PCR) and Western blot, respectively. Immunoglobulin A (IgA) secretion was measured by enzyme-linked immunosorbent assay after stimulation of isolated B cells with CpG-ODN, control GpC-ODN or lipopolysaccharide (LPS). Flow cytometric analysis of the isolated lamina propria mononuclear cells showed a purification of 73% (+/-22%) CD19(+) cells. By quantitative reverse transcription-PCR and by Western blot TLR-9 expression in this cell population was evident. IgA secretion was increased significantly by CpG-ODN incubation compared with GpC-ODN and LPS. Compared with unstimulated controls, CpG-ODN up-regulated IgA secretion to 139% (+/-21%). These data demonstrate that CD19(+) mucosal B cells express TLR-9 and secrete increased levels of IgA upon stimulation with CpG-ODN, indicating an additional link between adaptive and innate intestinal immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220839      PMCID: PMC2669530          DOI: 10.1111/j.1365-2249.2008.03855.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics.

Authors:  I N Farstad; H Carlsen; H C Morton; P Brandtzaeg
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  A role for Toll in autoimmunity.

Authors:  Arthur M Krieg
Journal:  Nat Immunol       Date:  2002-05       Impact factor: 25.606

Review 4.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 5.  Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut.

Authors:  Keiichiro Suzuki; Seon-ah Ha; Masayuki Tsuji; Sidonia Fagarasan
Journal:  Semin Immunol       Date:  2006-12-11       Impact factor: 11.130

Review 6.  The functional interactions of commensal bacteria with intestinal secretory IgA.

Authors:  Andrew J Macpherson; Emma Slack
Journal:  Curr Opin Gastroenterol       Date:  2007-11       Impact factor: 3.287

7.  TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Benigno Rodriguez; Richard J Mohner; Scott F Sieg
Journal:  Eur J Immunol       Date:  2007-08       Impact factor: 5.532

8.  CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils.

Authors:  Daryl S Spinner; Regina B Kascsak; Giuseppe Lafauci; Harry C Meeker; Xuemin Ye; Michael J Flory; Jae Il Kim; Georgia B Schuller-Levis; William R Levis; Thomas Wisniewski; Richard I Carp; Richard J Kascsak
Journal:  J Leukoc Biol       Date:  2007-03-22       Impact factor: 4.962

9.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

10.  Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.

Authors:  Parviz Ahmad-Nejad; Hans Häcker; Mark Rutz; Stefan Bauer; Ramunas M Vabulas; Hermann Wagner
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

View more
  17 in total

1.  Down-regulation of ATP-binding cassette transporter G1 expression by unmethylated CpG oligodeoxynucleotides in RAW 264.7 macrophages.

Authors:  Jeong Min Seo; Ji-Young Lee; Geun Eog Ji; Ji Chang You
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

Review 2.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

3.  Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy.

Authors:  Paola Lorena Smaldini; Andrés Esteban Ibañez; Carlos Alberto Fossati; Juliana Cassataro; Guillermo Horacio Docena
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching.

Authors:  Mijia Liu; Xueyan Bian; Li Wang; Guisen Li
Journal:  Front Med (Lausanne)       Date:  2022-07-06

5.  Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.

Authors:  Sukumar Kandasamy; Kuldeep S Chattha; Anastasia N Vlasova; Gireesh Rajashekara; Linda J Saif
Journal:  Gut Microbes       Date:  2014

6.  Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation.

Authors:  B Massonnet; A Delwail; J-M Ayrault; C Chagneau-Derrode; J-C Lecron; C Silvain
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

7.  Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients.

Authors:  Fabio Sallustio; Sharon N Cox; Grazia Serino; Claudia Curci; Francesco Pesce; Giuseppe De Palma; Aikaterini Papagianni; Dimitrios Kirmizis; Mario Falchi; Francesco P Schena
Journal:  Eur J Hum Genet       Date:  2014-10-08       Impact factor: 4.246

8.  Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine.

Authors:  Rong-Ti Ge; Li-Hua Mo; Ruijin Wu; Jiang-Qi Liu; Huan-Ping Zhang; Zhigang Liu; Zhanju Liu; Ping-Chang Yang
Journal:  Sci Rep       Date:  2015-01-15       Impact factor: 4.379

9.  In vivo dose response and in vitro mechanistic analysis of enhanced immunoglobulin A production by Lactobacillus plantarum AYA.

Authors:  Yosuke Kikuchi; Hikaru Yoshida; Tasuku Ogita; Kimiko Okita; Shin-Ichi Fukudome; Takuya Suzuki; Soichi Tanabe
Journal:  Biosci Microbiota Food Health       Date:  2015-03-14

Review 10.  Research progress on Toll-like receptor signal transduction and its roles in antimicrobial immune responses.

Authors:  Pengpeng Xia; Yunping Wu; Siqi Lian; Li Yan; Xia Meng; Qiangde Duan; Guoqiang Zhu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-28       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.